BioDrugs : Impact Factor & More
eISSN: 1179-190XpISSN: 1173-8804
Share this on:
Aims and Scope of BioDrugs
BioDrugs is a peer-reviewed pharmacology journal. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. It has a 2020 impact factor of 5.807. It is published by Adis International (SpringerNature). Less
Key Metrics
CiteScore 
10.5
Eigenfactor
0.001 - 0.005
H-Index
76
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.74
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on BioDrugs
BioDrugs Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in BioDrugs ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in BioDrugs
Conditionally Activatable Antibody Platforms: Mechanisms, Modalities, and Clinical Translation Potential.
- 1 Jan 2026
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Cell Engineering for Increasing Production of Recombinant Proteins in Mammalian Cells.
- 1 Jan 2026
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Biosimilar Uptake in Spain from 2016 to 2023: Analysis Based on Official Data Collection.
- 1 Jan 2026
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Harnessing Nanocarriers to Advance Vaccine Development.
- 15 Dec 2025
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Correction: Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
- 15 Dec 2025
- Biodrugs
Recombinant Molecules as a New Frontier in Mucositis Therapy.
- 2 Dec 2025
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Conditionally Activatable Antibody Platforms: Mechanisms, Modalities, and Clinical Translation Potential.
- 1 Jan 2026
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Cell Engineering for Increasing Production of Recombinant Proteins in Mammalian Cells.
- 1 Jan 2026
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Biosimilar Uptake in Spain from 2016 to 2023: Analysis Based on Official Data Collection.
- 1 Jan 2026
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Harnessing Nanocarriers to Advance Vaccine Development.
- 15 Dec 2025
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Correction: Can Alpha-Glucosidase Activity in Plasma or Leukocytes Serve as a Biomarker for Future Gene Therapy in Classic Infantile Pompe Disease?
- 15 Dec 2025
- Biodrugs
Recombinant Molecules as a New Frontier in Mucositis Therapy.
- 2 Dec 2025
- BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
FAQs on BioDrugs
How long has BioDrugs been actively publishing? 
What is the publishing frequency of BioDrugs?
How many articles did BioDrugs publish last year?
What is the eISSN & pISSN for BioDrugs?
What is Citescore for BioDrugs?
What is the H Index for BioDrugs ?
What is SNIP score for BioDrugs?
What is the SJR for BioDrugs?
Who is the publisher of BioDrugs?
